Health

Biogen’s Higher-Dose Spinraza Approval Is More Than a Regulatory Win

Health

The $2.75 Billion Bet: Why Big Pharma Is Going All In on AI Drug Discovery

Health

EU Warns of Extended Shortage of Baxter Cancer Drug Ifosfamide — Likely Lasting Into Early 2027

Health

Lilly’s Next-Gen Obesity Shot Just Posted Big Diabetes Results — and It’s a Warning Shot to the Whole GLP-1 Market

Mindflos

Mindflos is a dynamic platform dedicated to amplifying diverse voices and perspectives. We bring readers a rich blend of engaging content across entertainment, health, and culture—informing, inspiring, and sparking conversation. From insightful articles and human stories to lifestyle features and cultural explorations, we aim to reflect the pulse of modern society while promoting awareness, creativity, and well-being.